Open AccessP627: COMBINED DRUG AND CRISPR/CAS9 SCREENING REVEALS SPECIFIC TARGETS FOR SF3B1‐ AND NOTCH1‐MUTATED CLL CELLS
Author(s) -
Dostálová L.,
Ladungová A.,
Škrnová D.,
Varma Gottumukkala N.,
Lodhi Y.,
Smida M.
Publication year - 2022
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/01.hs9.0000845396.09812.76
Subject(s) - crispr , biology , cas9 , gene , chronic lymphocytic leukemia , mutation , point mutation , genetics , cancer research , drug discovery , computational biology , leukemia , bioinformatics